---All---
  • ---All---
  • Accession
  • Catalog #

CALM1 Antibody (Center K95)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP19118c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP19118c-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

CALM1 Antibody (Center K95) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP62158
Other AccessionP62155, P62161, P62160, P62204, Q6PI52, P62149, P62157, P02597, NP_001734.1
ReactivityHuman
PredictedBovine, Chicken, Mouse, Rat, Rabbit, Xenopus, Zebrafish
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW16838 Da

CALM1 Antibody (Center K95) - Additional info

Gene ID 808
Other Names
CALM1; CALM; CAM; CAM1; Calmodulin
Target/Specificity
This CALM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 81-110 amino acids from the Central region of human CALM1.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
CALM1 Antibody (Center K95) is for research use only and not for use in diagnostic or therapeutic procedures.

CALM1 Antibody (Center K95) - Protein Information

Name CALM1
Synonyms CALM, CAM, CAM1
Function
Calmodulin mediates the control of a large number of enzymes, ion channels and other proteins by Ca(2+). Among the enzymes to be stimulated by the calmodulin-Ca(2+) complex are a number of protein kinases and phosphatases. Together with CEP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis
Cellular Location
Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole. Note=Distributed throughout the cell during interphase, but during mitosis becomes dramatically localized to the spindle poles and the spindle microtubules

CALM1 Antibody (Center K95) - Related products

AP1570b: Calmodulin Antibody (C-term)

AP19118c: CALM1 Antibody (Center K95)

AP8549b: CALM1 Antibody (C-term)

RI10751: CALM1 predesign siRNA

RI10752: CALM2 predesign siRNA

RI10753: CALM3 predesign siRNA

DC00210: Human CALM1 cDNA Clone

DC02403: Human CALM2 cDNA Clone

BP1570b: Calmodulin Antibody (C-term) Blocking Peptide

BP8549b: CALM1 Antibody (C-term) Blocking Peptide

AJ1118a: Calmodulin Antibody (CaM) (C-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Calmodulin mediates the control of a large number of enzymes and other proteins by Ca(2+). Among the enzymes to be stimulated by the calmodulin-Ca(2+) complex are a number of protein kinases and phosphatases. Together with CEP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis.

REFERENCES

Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Mototani, H., et al. J. Bone Miner. Metab. 28(5):547-553(2010) Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Liu, Y.J., et al. Obesity (Silver Spring) (2010) In press : Benaim, G., et al. Eur. J. Biochem. 269(15):3619-3631(2002)